Previous Page  7 / 17 Next Page
Information
Show Menu
Previous Page 7 / 17 Next Page
Page Background

Page 59

Journal of Clinical & Experimental Pharmacology | ISSN: 2161-1459 | Volume: 8

International Conference on

July 18-19, 2018 | Atlanta, USA

Pharmacology and Ethnopharmacology

11

th

International Conference and Exhibition on

Pharmaceutical Oncology

&

Decision-making of cancer patients about end-of-life: The lived experience

Angela Katrina G Fonte

The Medical City, Philippines

U

nderstanding the perception of an end-stage cancer patient about end-of-life decision making can help the patient’s relatives,

healthcare providers, and the person himself or herself in attaining the best quality of life in their exit event. The aim of this study

is to deeply gain an understanding of the voice and feelings of stage 4 cancer patients in making decisions for end-of-life. The study

was conducted using a qualitative phenomenological approach. Five participants who are of sound mind and able to make rational

decisions shared their preferences. The participants were selected using a non-probability, criterion, purposive sampling. Data were

gathered through the use of a semi-structured interview. Four major themes emerged from the analysis of the data. The themes were

leaving protracted misery, divesting the burden, feeling of complacency and living in a former time. These themes encircle mainly

on the issue of a cycle of suffering and prolonging one’s agony with the use of life-saving measures which can reduce the quality of

life. Findings of the study revealed that end-of-life decision making is encapsulated with different factors which include physical

discomfort and exhaustion, emotional distress, spiritual dilemma and financial burden. Recommendations include educational

training for nurses about end-of-life care and discussion of ethical issues, culturally competent care, and management of patients

who are facing end-of-life decision making. It is also recommended that physicians should take the lead and explore the end-of-life

preferences of patients and their families.

katrinafonte@yahoo.com.ph

Clin Exp Pharmacol 2018, Volume: 8

DOI: 10.4172/2161-1459-C1-029